Privacy Policy

Galderma respects the privacy of every individual visiting our Web sites. Galderma's Privacy Policy, outlining the information Galderma collects and how Galderma uses such information is as follows:

Personally Identifiable Information

Galderma collects personally identifiable information (such as name, address, telephone/fax number and e-mail address) only when voluntarily provided by a visitor to our Web sites. Galderma does not sell, rent or otherwise make available any personally identifiable information submitted by visitors to our Web site to any third parties. This information will not be used for any direct marketing or unsolicited follow-up unless we have previously informed you of this possible use and you have given us your express permission when submitting it. After obtaining your consent, Galderma may use this information for such purposes as:

Only authorized Galderma staff or our agents (who have agreed to keep information secure) have access to personally identifiable information.

Galderma does make use of non-personally identifiable statistical information collected from users (browser type, geographical location, age, gender) for optimization of its sites as part of its continual internal review process and in a general way to learn more about its clients. This information will not be disclosed to third parties by Galderma. This data will only be used for the stated purpose and will not be used for any unsolicited communication unless you give us permission.

Log Files

We use IP addresses to analyze trends, administer the site, track user's movements, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Cookies

Galderma does use tracking technology (known as 'cookies'), which deposits certain bits of information on your hard drive. Cookies allow us to track and target your interests to tailor our sites to suit your needs better.

Children

Children and young people under the age of 16 are requested to get permission from their parent or guardian before they submit personal data to Galderma Web sites. We do not knowingly collect or use personally identifiable information from children under the age of 13 without first obtaining verifiable consent from a parent or legal guardian. Should a child whom we know to be under the age of 13 send personally identifiable information to us, we will only use that information to respond directly to that child, seek parental consent or provide parental notice.

Links

Links from this site may take you to other sites. Please be aware that we are not responsible for the privacy practices of such other sites. We advise you to check their privacy policies yourself before submitting any personally-identifiable information.

Changes

Using this Web site, you signify your agreement to the terms and conditions of this Privacy Policy. If you do not agree to these terms and conditions, please do not disclose any personally identifiable information though this Web site. This policy may be modified from time to time, and changes will be communicated promptly on this page. Please contact us for more information on this policy.

Webmaster
Galderma Laboratories, L.P.
Webmaster@galderma.com

IMPORTANT SAFETY INFORMATION

Dysport is a prescription injection for temporary improvement in the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age.

Important Safety Information

What is the most important information you should know about Dysport?

Spread of Toxin Effects: In some cases, the effects of Dysport and all botulinum toxin products may affect areas of the body away from the injection site. Symptoms can happen hours to weeks after injection and may include swallowing and breathing problems, loss of strength and muscle weakness all over the body, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, or loss of bladder control. Swallowing and breathing problems can be life threatening and there have been reports of death. You are at the highest risk if these problems are pre-existing before injection.

These effects could make it unsafe for you to drive a car, operate machinery, or do other dangerous activities.

Do not have Dysport treatment if you: are allergic to Dysport or any of its ingredients (see the end of the Medication Guide for a list of ingredients), are allergic to cow’s milk protein, had an allergic reaction to any other botulinum toxin product, such as Myobloc®, Botox®, or Xeomin®, have a skin infection at the planned injection site, under 18 years of age, or are pregnant or breastfeeding.

The dose of Dysport is not the same as the dose of any other botulinum toxin product and cannot be compared to the dose of any other product you may have used.

Tell your doctor about any swallowing or breathing difficulties and all your muscle or nerve conditions such as amyotrophic lateral sclerosis [ALS or Lou Gehrig’s disease], myasthenia gravis, or Lambert-Eaton syndrome, which may increase the risk of serious side effects including difficulty swallowing and difficulty breathing.

Tell your doctor about all of your medical conditions, including if you have surgical changes to your face, very weak muscles in the treatment area, any abnormal facial change, injection site inflammation, droopy eyelids or sagging eyelid folds, deep facial scars, thick oily skin, wrinkles that can’t be smoothed by spreading them apart, or if you are pregnant or breastfeeding or planning to become pregnant or breastfeed.

Tell your doctor about all the medicines you take, including prescription and nonprescription medicines, vitamins and herbal and other natural products. Using Dysport with certain other medicines may cause serious side effects. Do not start any new medicines while taking Dysport without talking to your doctor first.

Especially tell your doctor if you: have received any other botulinum toxin product, such as Myobloc® (rimabotulinumtoxinB), Botox® (onabotulinumtoxinA), or Xeomin® (incobotulinumtoxinA), in the last four months or any in the past (be sure your doctor knows exactly which product you received, have recently received an antibiotic by injection, take muscle relaxants, take an allergy or cold medicine, or take a sleep medicine.

Common Side Effects

The most common side effects are nose and throat irritation, headache, injection site pain, injection site skin reaction, upper respiratory tract infection, eyelid swelling, eyelid drooping, sinus inflammation, and nausea.

Ask your doctor if Dysport is right for you.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Dysport Full Prescribing Information including Medication Guide.